Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo.
- DOI
- 10.7150/thno.117900
- Published
- 2026
- Container
- Theranostics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7150/thno.117900,
title = {Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo.},
author = {Birappa G and Perumalsamy H and Hong SH and Gowda DAA and Chandrasekaran AP and Karapurkar JK and Rajkumar S and Balusamy SR and Jayachandran A and Baek KH and Lee J and Matam V and Kim WJ and Kim KS and Ramakrishna S and Suresh B},
year = {2026},
journal = {Theranostics},
doi = {10.7150/thno.117900},
url = {https://doi.org/10.7150/thno.117900}
}RIS
TY - JOUR TI - Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo. AU - Birappa G AU - Perumalsamy H AU - Hong SH AU - Gowda DAA AU - Chandrasekaran AP AU - Karapurkar JK AU - Rajkumar S AU - Balusamy SR AU - Jayachandran A AU - Baek KH AU - Lee J AU - Matam V AU - Kim WJ AU - Kim KS AU - Ramakrishna S AU - Suresh B PY - 2026 JO - Theranostics DO - 10.7150/thno.117900 UR - https://doi.org/10.7150/thno.117900 ER -
APA
G, B., H, P., SH, H., DAA, G., AP, C., JK, K., S, R., SR, B., A, J., KH, B., J, L., V, M., WJ, K., KS, K., S, R., & B, S. (2026). Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo.. Theranostics. https://doi.org/10.7150/thno.117900
Source records
- pubmed · retrieved 2026-09-27T12:37:28.913Z